Question 1

What is Qsymia?

Accepted Answer

Qsymia is a combination medication that contains phentermine and topiramate extended-release. It is designed to help with weight management by combining an appetite suppressant with an anticonvulsant medication. These two components work together to influence the brain's signals regarding hunger and satiety.

It works by affecting certain chemicals in the brain to help control appetite and cravings. This medication is intended to be used as part of a comprehensive weight management plan that includes lifestyle modifications.

Question 2

What is Qsymia used for?

Accepted Answer

Qsymia is used to treat chronic weight management .

Question 3

How does Qsymia work?

Accepted Answer

Mechanism of Action

Qsymia is a combination of two different medications: phentermine and topiramate. These drugs work through different mechanisms in the central nervous system to assist with weight management.

Phentermine

Phentermine is a sympathomimetic amine, which is a type of stimulant. It works by stimulating the release of norepinephrine in the brain. This chemical signal helps suppress the appetite, making you feel less hungry throughout the day.

Topiramate

Topiramate is an anticonvulsant medication. While the exact way it contributes to weight loss is not entirely clear, researchers believe it works by:

Increasing the feeling of being full ( satiety ).

Making foods taste less appealing to some people.

Increasing the amount of energy the body uses.

Together, these two components help reduce the overall amount of food a person eats, making it easier to follow a reduced-calorie diet and increase physical activity.

Question 4

What are the active ingredients in Qsymia?

Accepted Answer

The active ingredients in Qsymia are topiramate and phentermine .

Question 5

What are the side effects of Qsymia?

Accepted Answer

Common side effects of Qsymia may include:

dry mouth

constipation

tingling

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Qsymia?

Accepted Answer

Qsymia belongs to the weight management combination drug class.

Question 7

What is the dosage of Qsymia and how do I take it?

Accepted Answer

How to Take Qsymia

Qsymia should be taken exactly as directed by a healthcare provider. General instructions for use include:

Take the medication once daily, preferably in the morning.

Avoid taking doses late in the day or in the evening, as this may cause difficulty falling asleep or staying asleep.

The capsules can be taken with or without food.

Swallow the capsule whole. Do not crush, chew, or break the capsule before swallowing.

Missed Doses

If you miss a dose of Qsymia, skip the missed dose and take your next dose at the regular time the following morning. Do not take extra medicine or double doses to make up for a missed dose.

General Dosing Patterns

Healthcare providers usually start treatment with a lower dose and may gradually increase the dosage over several weeks based on how the patient responds to the medication. It is important to follow the specific titration schedule provided by your doctor and not to change your dose without medical consultation.

Question 8

Is Qsymia safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy Risks

Qsymia can cause serious harm to an unborn baby. One of its active ingredients, topiramate, significantly increases the risk of oral clefts (cleft lip or cleft palate) if a fetus is exposed during the first trimester of pregnancy. Because weight loss offers no potential benefit to a pregnant person and may cause fetal harm, this medication is contraindicated during pregnancy.

Requirements for Use

Due to the risk of birth defects, Qsymia is only available through a restricted program. Healthcare providers typically require the following for individuals who can become pregnant:

Pregnancy Testing: A negative pregnancy test must be confirmed before starting treatment and then every month during treatment.

Contraception: Effective birth control must be used consistently while taking the medication.

If you suspect you are pregnant or have a positive pregnancy test, you should stop taking Qsymia immediately and contact your healthcare provider.

Breastfeeding

It is not recommended to breastfeed while taking Qsymia. Both phentermine and topiramate can pass into breast milk. There is a potential for serious side effects in a nursing infant exposed to these medications. Patients should discuss alternative options with their healthcare provider to determine the safest course of action for both the parent and the child.

Question 9

What forms and strengths does Qsymia come in?

Accepted Answer

Qsymia is provided in the following form:

Extended-release capsules: These capsules are designed to be taken by mouth. They contain a combination of two active ingredients that are released gradually after ingestion.

The capsules are intended to be swallowed whole. Breaking, crushing, or chewing the capsules can interfere with how the medication is released into the system.

Question 10

What is the FDA approval status of Qsymia?

Accepted Answer

FDA Approval and Indications

The FDA approved Qsymia (phentermine and topiramate extended-release) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. It is indicated for the following groups:

Adults with an initial body mass index (BMI) of 30 kg/m² or greater (obese).

Adults with a BMI of 27 kg/m² or greater (overweight) who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.

Pediatric patients aged 12 years and older with a BMI in the 95th percentile or greater for their age and sex.

Risk Evaluation and Mitigation Strategy (REMS)

Because topiramate, one of the active ingredients in Qsymia, increases the risk of birth defects (specifically orofacial clefts) if taken during pregnancy, the FDA requires a Risk Evaluation and Mitigation Strategy (REMS). This program is designed to inform healthcare providers and patients of reproductive potential about the need for monthly pregnancy testing and the use of effective contraception while taking the medication.

Regulatory Classification

Qsymia contains phentermine, which is classified by the Drug Enforcement Administration (DEA) as a Schedule IV controlled substance. This classification is due to the potential for misuse or dependence. Regulatory guidelines require specific record-keeping and limit how the prescription can be refilled.

Safety Warnings

The FDA has issued warnings regarding several serious risks associated with Qsymia, including suicidal thoughts or actions, acute myopia (nearsightedness), and secondary angle-closure glaucoma. Patients are advised to monitor for changes in mood or vision and to seek immediate medical attention if these symptoms occur.

Question 11

What should I know about Qsymia and weight loss?

Accepted Answer

How Qsymia Works for Weight Loss

Qsymia contains two active ingredients, phentermine and topiramate, that work together to promote weight loss. Phentermine is an appetite suppressant that belongs to a class of drugs called sympathomimetic amines. It works by triggering the release of chemicals in the brain that help reduce hunger. Topiramate is an anti-seizure medication that helps weight loss by increasing the feeling of fullness and making foods taste less appealing to some people.

Who Can Use Qsymia

This medication is approved for chronic weight management in the following groups:

Adults: Those with a body mass index (BMI) of 30 or higher (obese), or a BMI of 27 or higher (overweight) who also have at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol.

Pediatric Patients: Children aged 12 years and older who have a BMI in the 95th percentile or higher for their age and sex.

Usage and Lifestyle

Qsymia is intended for long-term use but must be combined with lifestyle changes to be effective. This includes following a reduced-calorie diet and maintaining a regular exercise program. Healthcare providers typically monitor progress closely; if a specific amount of weight loss is not achieved within the first few months, the dosage may be adjusted or the medication may be discontinued.

Qsymia

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Weight Loss Information

FAQ

Found an Error?